In this study, we designed and synthesized a series of thiophen-2-iminothiazolidine derivatives from thiophen-2-thioureic with good anti-Trypanosoma cruzi activity. Several of the final compounds displayed remarkable trypanocidal activity. The ability of the new compounds to inhibit the activity of the enzyme cruzain, the major cysteine protease of T. cruzi, was also explored. The compounds 3b, 4b, 8b and 8c were the most active derivatives against amastigote form, with significant IC 50 values between 9.7 and 6.03 lM. The 8c derivative showed the highest potency against cruzain (IC 50 = 2.4 lM). Molecular docking study showed that this compound can interact with subsites S1 and S2 simultaneously, and the negative values for the theoretical energy binding (E b = À7.39 kcalÁmol À1 ) indicates interaction (via dipoledipole) between the hybridized sulfur sp 3 atom at the thiazolidine ring and Gly66. Finally, the results suggest that the thiophen-2-iminothiazolidines synthesized are important lead compounds for the continuing battle against Chagas disease.
Introduction
Neglected tropical diseases (NTDs) are a diverse group of diseases that prevail in tropical and subtropical countries and are responsible for causing illness in more than 1 billion people around the world. It has been estimated that around 8 million of these cases are associated with the parasite Trypanosoma cruzi, which causes Chagas disease. [1] [2] [3] This disease is controlled at present through the elimination of the vectors with the use of insecticides and the serological screening of blood. Better housing and educational campaigns are also fruitful approaches. As with other parasitic diseases, this pathology is associated with poverty and low educational levels. 4 Current chemotherapy for Chagas disease is unsatisfactory due to its limited efficacy, particularly in the chronic phase, with frequent side effects that can lead to the discontinuation of treatment. 5 The development of resistance by some strains of T. cruzi toward gold-standard drugs, such as nifurtimox and benznidazole ( Fig. 1) , represents a serious public health problem. 2 Also, these drugs present disadvantages that limit their use: they produce active metabolites which to interact with the DNA of the host leading to deleterious effects, such as cancer 6, 7 , resistance, lack of efficacy in the late-stage of the disease and a lack of pediatric formulations. 8 The survival of T. cruzi in the cells of the host is guaranteed by important enzymes (e.g. cruzain) which play a role in different processes including absorption, penetration, survival, infectivity, immune evasion, nutrition and growth.
the infection of host cells and the replication and metabolism of the parasite and it plays multiple roles in the disease pathogenesis. 4, 5 Furthermore, the selective inhibition of cysteine proteases as a therapeutic target has transcended the laboratory to the clinic. Recently, odanacatib ( Fig. 1) , a drug based on cysteine protease inhibition, has shown high efficacy and a good safety profile in Phase III clinical trials. Also, many studies in animal models have validated the use of this enzyme for the control and elimination of T. cruzi.
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Many thiophene compounds have been described as very active derivatives against T. cruzi ( Fig. 2 ) and these are interesting starting materials for new therapeutic agents. 9 The thiophene aromatic ring is a hydrophobic site which binds to the hydrophobic-pockets in some enzymes. 10 The pharmacological activity of thiazolidine compounds is of current interest. Thiazolidine and its hybrids have been reported to possess promising anticancer and antiviral properties. In addition, the thiazolidine scaffold is extremely important in the design and synthesis of novel biologically active agents with action against Trypanosoma spp.
11 Many compounds with the thiazolidine ring in their structure ( Fig. 3 ) have been described in the literature and they show promising anti-T. cruzi activity. 1, 5, 6, 11 In this study, we synthesized new thiophene-thiazolidine hybrid derivatives bearing various groups at the thiazolidine ring, with a linker (imine group) between the thiophene and thiazolidine rings (Fig. 4 ). All derivatives were tested for their ability to inhibit the in vitro growth of amastigote and trypomastigote forms of Trypanosoma cruzi and the activity of the enzyme cruzain. In addition, we carried out theoretical studies involving molecular docking simulations and pharmacophoric identification.
Results and discussion

Chemistry
The 2-aminothiophene analogues (1, 2) were readily prepared via the Gewald reaction, a multicomponent synthesis involving an aldehyde or ketone, an activated nitrile and elemental sulfur. [12] [13] [14] The intermediates (3a-d) were then synthesized through the treatment of 1 or 2 with substituted isothiocyanates (phenyl and allyl). Spectral analysis for these compounds was carried out according to methods described in the literature. 13, 15 Finally, thiophen-2-iminothiazolidines were prepared via thia-Michael cyclization (7a-d) or substitution followed by intramolecular cyclization (4a-d, 5c, d, 6a, 6c and 8a-d) between thiophen-2-thiourea and dielectrophiles. 16, 17 All of these reactions proceeded well with refluxing overnight. The synthetic route is shown in Scheme 1. Four compounds previously designed were not included in this work (two cyclization using ethyl 2-chloro acetate and two using 2-bromomalonate) due the formation of many secondary products and impossibility of purification by recrystallization or flash column chromatography. 161.99-163.60 ppm assigned to C@N and C@O moieties, respectively. For compounds 5c and 5d, resonated peaks at 2.57-2.60 ppm in the 1 H NMR were attributed to substituent methyl groups at C-4 of thiazolidine ring and whose carbons appeared at 12.85-12.90 ppm in the 13 C NMR spectra. Compounds 6a, 6c, 7a-d and 8a-d may be distinguished by the resonated peaks of SCH moiety, which appears as a singlet at 5.28-6.08 ppm in 1 H NMR of derivatives 6a and 6c. On the other hand, for compounds 7a-d the 1 H NMR spectra exhibited resonance assigned to the SCH group appearing as double doublet at 4.39-4.53 ppm, due to the interaction with methylene protons of the acetyl group substituent at C-5 of the 4-thiazolidinone ring. For these compounds, the SCH moiety ranges from 43.81 to 59.94 ppm in the 13 C NMR. Lastly, compounds 8a-d show resonated peaks for SCH further displaced downfield, with 13 C NMR signals being shown at 99.11-100.49 ppm.
The mechanism of thiazolidine ring formation is not well understood, which has led to erroneous proposal of structures obtained through the reaction of thiourea analogues with a-halo esters or acids in the presence of an inorganic base. 18 In the synthesis of 7a-d, for example, it is accepted that this reaction begins with a nucleophilic attack by the sulfur atom of the thiourea on the C@C bond of maleic anhydride, followed by a proton transfer and a nucleophilic attack of a nitrogen atom on any of the two carbonyl groups, providing a five-membered 4-oxo-1,3-thiazolidine ring. Finally, aminolysis of this product occurs, giving the final compound with an acid function. 19, 20 In ethanol reflux this reaction leads to many collateral products. Therefore, an aprotic solvent, such as toluene, was employed and satisfactory yields were obtained.
The general mechanism suggested is that the sulfur atom (soft nucleophile) of the thiourea will preferentially attack the a-halo esters (soft electrophile) and the NH (hard nucleophile) will attack the carbonyl center (hard electrophile). 18 However, the regioselectivity of the nucleophilic attack from the non-equivalent nitrogen atoms of the thiourea still needs to be studied. 20 For unsymmetrical thioureas (R1 -R2), regiocontrol in the cyclization step is typically influenced by electronic factors that predispose electronwithdrawing substituents (i.e., aryl or heteroaryl groups) to maintain conjugative stabilization with the imine nitrogen. 21 In the case of the thiophen-2-iminothiazolidines described herein, the results of analysis using heteronuclear multiple bond correlation (HMBC) (see Fig. 5 for 4c and supplementary data for the other compounds containing an allyl group) techniques support our conclusions regarding the position of the thiazolidine ring and the possibility of the existence of an ambiguous synthetic route is discarded (Scheme 2).
Additionally, we performed a molecular modeling study using the structures of the intermediary and transition state of the synthetic route for compounds 3a to 4a (Scheme 3). A lower transition state energy value and, consequently, a smaller energy difference value for the intermediary of this route, verify that this is a favorable synthetic route for obtaining the product formed (Table 1) . Also, the HOMO and LUMO energy gaps of both intermediaries were calculated and the energy gap value for ethyl 2-{[N- [3- Therefore, the HOMO-LUMO interactions of the latter are stronger than those of the former, corroborating with the results obtained for the transition state energies and from the spectral data.
In an attempt to improve the yield for the cyclization, the synthesis of 4b and 8a were chosen, and sodium acetate was used as a catalyst. However, it was observed that this did not lead to the formation of the desired compound (Scheme 4), since the base deprotonates the nitrogen neighboring to the phenyl group which, in turn, attacks the carbonyl of the ester group, closing the ring and providing the monosodium salt of the corresponding thienopyrimidine. Finally, thienopyrimidine salt reacts with the electrophile, leading to 9 and 10 as final products. The reason for this is that thienopyrimidines can be obtained from thiourea derivatives using a base salt. [22] [23] [24] Compound 9 was obtained as colorless crystals and its structure was confirmed by X-ray crystallography ( Fig. 6A ; Table 2 ). Yellow crystal of the compound 8b, obtained from cyclization without sodium acetate, is shown in Fig. 6B , as well crystal data and structure refinement are described in Table 2 .
Cytotoxicity of thiophen-2-thiourea and thiophen-2-iminothiazolidines
The cytotoxicity of the final compounds was evaluated using the MTT assay. Good tolerance was observed for most of the compounds when tested against the J774 macrophages cell line at a concentration of 10 lM. Only 4b presented significant cytotoxicity. The compounds 3b, 8b and 8c showed cell viability (J774) above 50% at 10 lM (Graphic 1).
Biological evaluation
The newly synthesized compounds were evaluated by in vitro screening against the amastigote and trypomastigote forms of the T. cruzi parasite. 25 A study on cruzain inhibition was carried out using the method described by Ferreira et al. 26 2.3.1. Assessment of compound activity against intracellular amastigotes The amastigote stage was shown to be infective toward phagocytic and non-phagocytic cells, an important process during the cycle in different hosts. The amastigotes multiply by binary fission in the cells of infected tissues. In addition, these evolutionary forms are related to the chronic phase of Chagas disease. 27 The results for activity against the intracellular amastigotes forms are shown in Table 3 . Benznidazole (BnZ), with a low IC 50 value (1.17 lM), was used as the positive control. In general, the molecular hybridization strategy can be considered satisfactory, due the cyclization of the compounds increased their potency against the amastigote forms, as observed on comparing 3b with 4b and 8b, and 3c with 8c.
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Furthermore, is possible to observe that the combination of ethyl and allyl groups at R 1 and R 2 , respectively, leads to lower activity (IC 50 value increases from 6.03 to 9.7 lM). Therefore, these chemical groups can be considered as unfavorable in relation to activity against these evolutionary forms. Additionally, an i-propyl group at R 1 and phenyl group at R 2 seems to be the best combination, increasing the activity, as observed for 3b, 4b and 8b, with IC 50 values between 8.78 and 6.03 lM. According to Kryshchyshyn et al. 6 , this is related to the hydrophobicity of the compounds, which leads to an increase in the activity toward evolutionary forms of the T. cruzi parasite. However, 8c, which has an allyl group at R 2 (unfavorable), showed a similar IC 50 value when compared with 3b. This fact can be attributed to the presence of a phenyl ring at R 5 in the structure of 8b, which increases the hydrophobic surface of this compound.
Activity against Y strain trypomastigotes
Intracellular amastigotes transform into trypomastigotes and then burst out of the cell and enter the bloodstream. Trypomastigotes can infect other cells and transform into intracellular amastigotes at new infection sites. The clinical manifestations can result from this infective cycle. 27 All results for anti-T. cruzi activity against Y strain trypomastigote forms at a concentration of 25 lM are shown in Table 4 . Only 4d showed significant inhibition against these parasite forms and its IC 50 value was lower than that of BnZ (10.3 and 11.4 lM, respectively). 
Cruzain inhibition
Cruzain inhibition by thiophen-2-thiourea and thiophen-2-iminothiazolidine derivatives was investigated as a possible mechanism of trypanocidal activity against T. cruzi (Table 5) . Of the compounds which were most effective against amastigote and trypomastigote forms of T. cruzi, 8c showed the highest potency against cruzain (IC 50 = 2.4 lM). Additionally, 5c, 7a, 7c and 7d were also active against the enzyme cruzain, but with moderate potencies. To determine whether the observed activity of the thiophene derivatives 5c, 7a, 7c, 7d and 8c was due to nonspecific binding, the assay was repeated in the absence and presence of 0.01 and 0.1% Triton X-100. 30 Compound 5c showed a higher cruzain inhibition in the absence of the detergent, possibly indicating aggregation. On the other hand, the level of cruzain inhibition for compounds 7a, 7c, 7d and 8c did not vary considerably in the presence of the different Triton concentrations, suggesting that the enzyme inhibition is not due to compound aggregation. Additionally, the IC 50 value for 7c did not increase in the presence of 2 mgÁmL À1 bovine serum albumin (BSA), with 42 and 50% inhibition of the enzyme at 50 lM in the presence and absence of BSA, respectively. This compound was not sensitive to pre-incubation with BSA, which, at high concentrations competes with the enzyme for colloid particles (aggregates), preventing or reducing enzymatic inhibition due to aggregation.
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Scheme 4. Synthetic routes for the compounds 9 and 10. 
Molecular docking studies
Since 2008, computational methodologies such as molecular docking and high-throughput screening (HTS) have been employed to providing new scaffolds with high potency and good tolerance. 8 Molecular docking models have been shown to adequately predict the binding mode associated with the binding of different anti-T. cruzi compounds to cruzain. 4 Therefore, in order to gain a better insight into the nature of the trypanocidal activity displayed by the novel thiophen-2-iminothiazolidine reported herein, molecular docking studies were performed with cruzain. The most active compound (8c) against amastigote forms and the enzyme cruzain provided a negative values for the theoretical energy binding (E b = À7.39 kcalÁmol À1 ). This indicates interaction (via dipoledipole) between the hybridized sulfur sp 3 atom at the thiazolidine ring and Gly66 (Fig. 7) . 5, 29 According to Martinez-Moyaorga et al. 8 this amino acid is the main key residue related to anti-T. cruzi activity, and interactions with water molecules are not associated with inhibitory activity. Normally, in a complex of hydrophobic compounds with the enzyme cruzain, a phenyl ring (when present) is allocated to the S2 subsite pocket and this is observed to be related to an increase the binding affinity. 8 Based on this, the cruzain subsite analysis
shows that compound 8c can interact with subsites S1 and S2 simultaneously. For this compound, the phenyl ring is allocated to S2 (high hydrophobicity) and the tetrahydrobenzothiophene bicycle is allocated to S1 (low hydrophobicity) (Fig. 8) . In addition, docking results showed that the compounds 5c, 7a, 7c and 7d does not provided satisfatory E b values in comparison with 8c, and are not able to interact with Gly66 amino acid.
Conclusion
In this study new thiazolidine based conjugates with the thiophene moiety in position 2 are described using accessible methods. The assay to determine the trypanocidal activity of synthesized compounds allowed us to identify thiophene-thiourea hybrid 3b and thiophene-thiazolidine hybrids 4b, 8b and 8c, which were found to be the most active derivatives against amastigote form, with significant IC 50 values between 9.7 and 6.03 lM. In addition, 
Procedure for synthesis of 2-aminothiophene (1,2)
A mixture of cyclohexanone (1 mmol), an activated nitrile (1 equiv), morpholine (1 equiv) and elemental sulfur (1 equiv) in 5 ml of ethanol was stirred at 0°C overnight. After, the solvent was evaporated at reduced pressure and the crude product was extracted with ethyl acetate thrice. The organic layer was treated with anhydrous sodium sulphate and evaporated again. Finally the final compounds were purified by recrystallization from MeOH/water. After, the solvent was evaporated at reduced pressure and the crude product was extracted with ethyl acetate thrice. The organic layer was treated with anhydrous sodium sulphate and evaporated again. Subsequently, was performed a flash chromatography using hexane/ethyl acetate (8:2) as eluent. Finally, the product was recrystallized from MeOH/water. 
Ethyl 2-(3-phenylthioureido)-4,5,6,7-tetrahydrobenzo [b]thiophene-3-carboxylate (3a
Procedure for synthesis of thiophen-2-thiazolidine (4a-d, 5c,d, 6a, 6c, 7a-d and 8a-d)
A mixture of thiophen-2-thiourea (1 mmol) and the respectively dielectrophile (1.0 equiv) in 15 ml ethanol (for synthesis of 7a-d was utilized toluene) was stirred until reflux overnight. After, the solvent was evaporated at reduced pressure and the crude product was extracted with ethyl acetate thrice. The organic layer was treated with anhydrous sodium sulphate and evaporated again. Finally the final compounds were purified by flash chromatography using hexane/ethyl acetate (8:2) as eluent. 
Crystallography
Crystallographic data were collected on a Bruker diffractometer at 296 K. The frames were integrated with the Bruker SAINT software package using a narrow-frame algorithm. Data reduction and empirical absorption corrections were carried out using the multi-scan method (SADABS). The structure was solved by direct methods and refined with SHELXS97. 31 All non-H-atoms were refined anisotropically and H-atoms were constrained at their estimated positions using a riding model. The thermal ellipsoid diagram was generated with ORTEP3. 32 The crystals were isolated from a tetrahydrofuran and hexane mixture at room temperature. The fractional atomic coordinates and isotropic temperature parameters (Å 2 ), the interatomic bond distances (Å) and angles (-) and the view of the packing showing the inter-and intramolecular interactions that stabilize the crystal structures for 9 and 8b can be found in the supplementary material.
Cytotoxicity assay (MTT)
The cytotoxicity was evaluated using the enzymatic reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to produce formazan crystals. 
Toxicity toward Y strain trypomastigotes
Trypomastigotes collected from the supernatant of LLC-MK2 cells were dispensed into 96-well plates at a cell density of 4.0 Â 10 5 cells/well. Test inhibitors, dissolved in DMSO, were diluted into five different concentrations, adjusted to 25 lM and added to the respective wells. The plate was then incubated for 24 h at 37°C in 5% CO 2 . In the next step, propidium iodide (400 ngÁmL
À1
) was added and the test samples were incubated for 5 min. Aliquots of each well were collected and the number of viable parasites, based on parasite motility, was assessed in a Neubauer chamber. The percentage of inhibition was calculated in relation to untreated cultures. The IC 50 was calculated using non-linear regression with the Prism 4.0 GraphPad software. Benznidazole was used as the reference drug. 
Cruzain inhibition
Procruzain truncated at the C-terminal was expressed and purified using a modified protocol (Lee, Balouch and Craik, unpublished results). A 0.5 mgÁmL À1 solution of procruzain (in 100 mM sodium acetate pH 5.5, 10 mM EDTA, 5 mM DTT and 1 M NaCl, pH adjusted to dialyzed in 10 mM Tris buffer pH 7.5, inhibited with the covalent reversible inhibitor methyl methanethiosulfonate (MMTS), and dialyzed again in the same buffer. Finally, the protein was purified in a MONO-Q anion exchange column, using 0-500 mM NaCl gradient in 10 mM Tris buffer (pH 7.5). 35 Cruzain activity was measured by monitoring the cleavage of the fluorescent substrate Z-Phe-Arg-aminomethylcoumarin (Z-FR-AMC), in a Synergy 2 (Biotek) fluorimeter, at the Centre for Flow Cytometry Fluorimetry at the Department of Biochemistry and Immunology (UFMG). All assays were performed in the 96-well plate format, with a final volume of 200 lL, in a buffer solution of 0.1 M sodium acetate pH 5.5 in the presence of 0.1 mM of betamercaptoethanol, 0.01% of Triton X-100, 0.5 nM of cruzain and 2.5 lM of substrate. 26 The assay was performed with and without the pre-incubation of the compounds with the enzyme. The initial screening was performed with 100 lM of the inhibitors, except for compounds 5d and 8a, which were assayed at 25 and 50 lM, respectively, due to solubility limitations. For each assay, two independent experiments were performed, each in triplicate and monitored for 5 min. Enzymatic activity was calculated based on a comparison with a DMSO control, considering the initial reaction rate. E64 (100 lM) was used in the assay as a positive control. Since most compounds were observed to be time-dependent, which is consistent with a covalent mode of inhibition, all subsequent assays were performed with 10 min of preincubation. The IC 50 curves were determined in two independent experiments, each involving at least nine compound concentrations, in triplicate. IC 50 curves were determined with GraphPad Prism. The most potent compounds were further evaluated for detergent-sensitivity at different concentrations (0.01% and 0.1% Triton X-100) at a concentration close to its IC 50 . The compound 7c was also pre-incubated in the presence of 2 mgÁmL À1 BSA to evaluate the formation of aggregates. 26 
Molecular docking
For docking purposes, the three-dimensional structure of cruzain (PDB code: 1U9Q) was obtained from the RCSB protein databank. Ligands that were already present within the receptor in bound form were removed for the docking protocol. All of the ligands were prepared and docked for this study in flexible docking mode and atoms located within a range of 5.0 Å from the amino acid residues were included in the active site. The docking calculations and minimization were carried out in the ArgusLab Ò module, with the Merck Molecular Force Field (MMFF), and most of the parameters had a set default with 10.000 cycles per molecule for the active site cavity. For the preparation of the macromolecule, all heteroatoms, including water molecules, were deleted. Polar hydrogen atoms were added to the cruzain tree-dimensional structure. The partial atomic charges of the cruzain and thiophen-2-thiourea and 2-iminothiazolidine derivatives were then calculated using Kollman and Gasteiger-Marsili methods, respectively. The cruzain was placed inside a box with the number of center grid points in X Â Y Â Z directions being 2.77 Â 10.289 Â 6.45 and a grid spacing of 0.375 Å. Lamarckian genetic algorithms were employed to perform the docking calculations. The number of genetic algorithm runs and the number of evaluations were set to 100 and 2.5 million, respectively. For all other parameters default settings were used. For each of the docking cases, the lowest energy docked conformation, according to the AutoDock scoring function, was selected as the binding mode. Molecular models were built to discuss the binding modes by docking using an AutoDock Tools program.
